Business Wire

NY-BILL-BLASS

Share
Bill Blass Set to Launch Globally November 2nd

Established in 1970, Bill Blass led the way for American designer brands. Today, the brand is poised to re-enter the market with a thoroughly modern strategy, catering exclusively to eCommerce customers worldwide. The launch collection, designed under Creative Director Chris Benz, includes women’s ready-to-wear, handbags, accessories and shoes, shipping to over 65 countries beginning November 2nd.

The pure-play eCommerce strategy was born from a desire to service consumers in the most responsive and contemporary way. “We are advancing the brand in a way that is digital for today and tomorrow while honoring the brand’s philosophical origin and illustrious past,” says Bill Blass President & COO, Stuart Goldblatt.

Breathing new life into the Bill Blass brand is Chris Benz, a young designer with an eponymous line already under his belt, who will use his social media savvy – he has over 200,000 followers – to engage with customers. “Bill Blass used the most relevant methods [at the time] to reach his customer directly and we will continue that ethos, creating a new, modern dialogue.” Benz is supported in these communications by an in-house digital marketing team.

Today, the Bill Blass team is honoring the brand more rigorously than the brand has been since Mr. Blass’ reign. Benz is mindful however of catering to the modern woman, noting, "looking to the future, one must respect the past and forge ahead leveraging the design history as a language rather than a blueprint.”

Rounding out the executive team is Business Director Kelly DeMeester, who joined the team following years of experience in the finance industry. DeMeester notes, "There is a ubiquitous disclaimer in investment reporting, ‘Past performance does not guarantee future results.’ To some degree this is also true for fashion." Underpinning her strategic business approach, DeMeester believes, "applying technology and tapping into consumer behavior to enhance the user experience will foster deeper, more personal engagement.”

The brand will be supported by a strong technology platform and will launch with a custom-built eCommerce website–www.billblass.com . Bill Blass is able to change the site’s content and merchandise in-house, managing a continuous flow of new product. The focus, rather than tied to traditional seasonal delivery schedules, is to present an ongoing stream of product for global distribution. To enhance the company’s agility, Bill Blass has created a state-of-the-art, in-house digital studio where new product can seamlessly go from photography to online availability in record time.

On the eve of the brand’s launch, Goldblatt sums up the spirit of the new team: “Everyone at Bill Blass is passionate about infusing vitality into one of the greatest fashion brands in history. We are committed to investing in our future and creating the foundation for a vibrant global brand, led through eCommerce.”

Contact:

Bill Blass
Lisa Smith, 212-689-8955
lisa@billblass.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

TreeFrog Therapeutics Presents Delivery Strategy for Next Generation 3D Cell Therapy Format for Parkinson’s Disease at the 28th Annual ASGCT Meeting in New Orleans13.5.2025 08:00:00 CEST | Press release

TreeFrog Therapeutics is the first company to present publicly a clinical-ready delivery strategy for 3D format microtissues in cell therapy.After four years in development, the validated device and delivery strategy overcomes challenges of 3D formats and uses existing stereotactic components to support adoption through ease of delivery education. TreeFrog Therapeutics, a French biotech specializing in cell therapy is the first company to present a clinical-ready delivery strategy for 3D microtissues cell therapy. The validated approach was demonstrated for their 3D neural microtissues cell therapy treatment for Parkinson’s disease. Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s disease. It is a progressive disease characterized by the loss of dopaminergic neurons with a mix of motor symptoms (bradykinesia, rigidity, resting tremor) and non-motor symptoms (cognitive deficits, mood disorders, fatigue). Current treatments provide symptomatic re

Ohana Development Launches ‘Jacob & Co. Beachfront Living by Ohana,’ A Masterpiece of Beachfront Elegance in the UAE13.5.2025 08:00:00 CEST | Press release

Valued at USD 1.3 billion, the project offers world-class amenities, including a signature Jacob & Co. ceiling art timepiece, the largest of its kind globally. Ohana Development, the leading real estate developer renowned for its luxury properties, has launched ‘Jacob & Co. Beachfront Living by Ohana’ in partnership with luxury timepiece and jewellery house Jacob & Co. The project was revealed at Emirates Palace Mandarin Oriental, Abu Dhabi. Located in Al Jurf between Dubai and Abu Dhabi, this USD 1.3 billion development blends natural surroundings with exceptional artistry and craftsmanship. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512533615/en/ Jacob & Co. Beachfront Living by Ohana. (Photo: AETOSWire) Jacob & Co. Beachfront Living by Ohana presents 457 residences comprising of sea-view apartments, villas, penthouses, Sky Mansions, and beachfront mansions—each capturing the spirit of refined coastal living. Pentho

Azafaros Secures € 132M in Oversubscribed Series B Financing to Advance Phase 3 Clinical Programs of Innovative Therapies in Lysosomal Storage Disorders13.5.2025 07:00:00 CEST | Press release

Financing round led by Jeito Capital and co-led by Forbion Growth, with participation from Seroba, Pictet Group and other existing investorsProceeds to fund two Phase 3 pivotal programs with nizubaglustat, lead asset in Niemann-Pick disease Type C (NPC) and GM1/GM2 gangliosidoses as well as expanding the Azafaros pipeline to other indicationsNizubaglustat has been awarded Orphan Drug Designation in both the US and Europe as well as Fast-track status in the US. The company expects to initiate both Phase 3 studies later this year Azafaros, a clinical-stage company focused on developing disease-modifying therapeutics to offer new treatment options to patients with rare lysosomal storage disorders, announces the completion of an oversubscribed €132M Series B financing led by Jeito Capital, co-led by Forbion Growth and with additional participation from Seroba, Pictet Group and existing investors Forbion Ventures, Schroders Capital and BioGeneration Ventures (BGV). This financing enables Az

Presidio Investors is Pleased to Announce the Addition of Christian Schütte as Its Newest Operating Partner12.5.2025 19:04:00 CEST | Press release

Christian brings more than 20 years of global experience in investment banking, private equity, and operational leadership, with a proven track record of driving transformational growth across industries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512473756/en/ Christian Schütte Christian began his career at J.P. Morgan in New York and London, where he worked in the M&A and Corporate Finance teams. He later joined Fortress Investment Group and was instrumental in launching its German operations. During his tenure, he helped raise over €1.5 billion in equity and managed a wide array of investments, including non-performing and performing loans, private and public companies. He went on to join EQT Group, where he focused on mid-market growth and succession investments. Notably, he led the consolidation of nine digital marketing agencies into a €100 million market leader, building one of the most comprehensive digital ma

Introducing Joblio – The Future of Ethical Recruitment12.5.2025 18:30:00 CEST | Press release

Joblio Launches to Revolutionize Ethical Recruitment and End Worker Exploitation Joblio, a global ethical recruitment platform, officially launches today to tackle the broken labor migration system—long plagued by exploitative intermediaries, high recruitment fees, and human rights abuses. With its tech-driven model, Joblio connects vetted workers with employers directly, eliminating unethical middlemen and ensuring cost-free hiring for migrant workers. Employers fund access to talent, but workers never pay—a key step in ending exploitation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512628048/en/ A Mission Rooted in Personal Experience Joblio is led by Jon Purizhansky, a refugee-turned-entrepreneur who experienced migration challenges firsthand. Forced to flee his home country as a young man, Jon faced the uncertainty and vulnerability that millions of migrant workers still encounter today. Now a globally recognized

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye